MDY Mdy Healthcare

RNS No 0386f
MEDISYS PLC
25th August 1998


                    FDA APPROVAL FOR NICSAFE 2800

Medisys plc ("Medisys"), the medical devices group, announces that the US Food
and Drug Administration ("FDA") has approved its NicSafe 2800 portable needle
disposal system for marketing in the United States.

The NicSafe 2800, the first and only US FDA-approved device of its kind,
instantly destroys hypodermic needles at the point of use, utilising a
rechargeable battery to enhance mobility.  The system is marketed to medical
institutions and private practitioners as a cost-effective way of disposing of
used needles that can also reduce incidence of accidental needlestick injuries
among healthcare workers.  It is estimated that, in the US, there are
approximately one million needlestick injuries reported every year, creating
an annual cost of $3 billion to healthcare providers for associated testing
and medical treatment.  Medisys estimates that these figures could be doubled
on a world-wide basis.

The NicSafe 2800 portable joins the NicSafe 1800, currently marketed in some
25 countries in Europe, Asia and the Americas.

Kurt Amundson, Chief Operating Officer of Medisys, said:

"The NicSafe 2800 portable is an important addition to our safety product
range.  It will accompany the medication trolley or field inoculation
programmes, to provide instant point-of-care destruction of used needles.
This enhancement to healthcare worker safety is a significant step in
improving work conditions and containing healthcare costs."

Enquiries:

Gavin Anderson & Company                               Tel:  0171 457 2345
David Yates / Sophie Pender-Cudlip


END


MSCDBGBIDUDCCIS

MDY Healthcare (LSE:MDY)
Historical Stock Chart
Von Jun 2024 bis Jul 2024

MDY Healthcare (LSE:MDY)
Historical Stock Chart
Von Jul 2023 bis Jul 2024